Quoin Pharmaceuticals, Ltd. (QNRX) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 21.62M |
| Enterprise Value | -3.8B |
| P/E Ratio | -0.41 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.66 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.13 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -0.57 |
| Return On Equity | -1.44 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -15.7M |
| Net Income | -15.8M |
| Diluted EPS | -10.63 |
| Total Cash | 10.1M |
| Total Cash/Share | 2 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 7.2 |
| Book Value Per Share | 5.69 |
| 52-Week Change | -67.33 |
| 52-Week High | 23.5 |
| 52-Week Low | 3.25 |
| Moving Average 50 Days | 5.2 |
| Moving Average 200 Days | 5.84 |
| Average Volume | 544,164 |
| Shares Outstanding | 2.01M |
| % Held by Institutions | 64.7 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
| Last Split Date | July 18, 2023 |